Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Sleep medicine reviews"
DOI: 10.1016/j.smrv.2016.09.004
Abstract: Suvorexant is a dual orexin receptor agonist and is currently approved for the treatment of insomnia in the United States and Japan. We conducted a systematic review and meta-analysis to assess the efficacy and safety… read more here.
Keywords: primary insomnia; suvorexant treatment; insomnia; analysis ... See more keywords